ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/083/ERR11758183/ERR11758183.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/094/ERR11758194/ERR11758194.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/086/ERR11758186/ERR11758186.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/080/ERR11758180/ERR11758180.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/075/ERR11758175/ERR11758175.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/077/ERR11758177/ERR11758177.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/091/ERR11758191/ERR11758191.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/092/ERR11758192/ERR11758192.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/088/ERR11758188/ERR11758188.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/095/ERR11758195/ERR11758195.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/089/ERR11758189/ERR11758189.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/078/ERR11758178/ERR11758178.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/082/ERR11758182/ERR11758182.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/073/ERR11758173/ERR11758173.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/084/ERR11758184/ERR11758184.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/087/ERR11758187/ERR11758187.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/090/ERR11758190/ERR11758190.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/093/ERR11758193/ERR11758193.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/076/ERR11758176/ERR11758176.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/081/ERR11758181/ERR11758181.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/085/ERR11758185/ERR11758185.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/074/ERR11758174/ERR11758174.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/079/ERR11758179/ERR11758179.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR117/096/ERR11758196/ERR11758196.fastq.gzprimaryOK200GenomicsDNA Replication and Cancer Group, Danish Cancer InstituteEuropean Bioinformatics Institutehttps://www.ebi.ac.uk/ena/browser/view/PRJEB64552ArrayExpressInvestigation of transcriptome changes in four human cell lines (BJ, BJ-5ta, U2OS and HeLa) after treatment for 24 hours with nicotinamide adenine dinucleotide (NAD+). Cells were untreated as the control condition. Nanopore sequencing of cDNA was performed after library preparation with the ONT SQK-PCB109 kit.ENAfalseNanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+)Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+)2023-09-212023-09-21PRJEB64552